Effect of intra-articular infliximab on synovial membrane pathology in a patient with a seronegative spondyloarthropathy

Annals of the Rheumatic Diseases

Volumn 67, Issue 9, 2008, Pages 1339-1342

  Ahern, M J ^a   Campbell, D G ^a   Weedon, H ^a   Papangelis, V ^a   Smith, M D ^a,b  

^a REPATRIATION GENERAL HOSPITAL   (Australia)

^b South Australian Clinical Genetics Service   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; INFLIXIMAB; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; METHOTREXATE; SALAZOSULFAPYRIDINE; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; ANAMNESIS; ARTHROSCOPIC SURGERY; ARTICLE; CASE REPORT; CELL ADHESION; CELL INFILTRATION; CONTROLLED STUDY; DIGITAL IMAGING; DRUG EFFECT; FEMALE; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; JOINT BIOPSY; KNEE ARTHRITIS; LABORATORY TEST; MONARTHRITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REMISSION; SCORING SYSTEM; SEROLOGY; SPONDYLOARTHROPATHY; SYNOVECTOMY; SYNOVITIS; TREATMENT OUTCOME;

ADULT; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; BIOPSY; FEMALE; HUMANS; INJECTIONS, INTRA-ARTICULAR; SPONDYLARTHROPATHIES; SYNOVIAL MEMBRANE; SYNOVITIS;

EID: 50249183527     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2008.090910     Document Type: Article

References (13)

1. Maini R, St Clair EW, Breedveld F, Furst D, Kalden J, Weisman M, et al. Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomized phase III trial. ATTRACT Study Group. Lancet 1999;354:1932-9.
2. Antoni C, Krueger GG, de Vlam K, Birbara C, Beutler A, Guzzo C, et al. For the IMPACT 2 Investigators. Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial. Ann Rheum Dis 2005;64:1150-7.
3. Braun J, Brandt J, Listing J, Zink A, Alten R, Golden W, et al. Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial. Lancet 2002;359:1187-93.
4. Bokarewa M, Tarkowski A. Local infusion of infliximab for the treatment of acute joint inflammation. Ann Rheum Dis 2003;62:783- 4.
5. Nikas SN, Temekonidis TI, Zikou AK, Argyropoulou MI, Efremidis S, Drosos AA. Treatment of resistant rheumatoid arthritis by intra-articular infliximab injections: a pilot study. Ann Rheum Dis 2004;63:102-3.
6. 99mTc-infliximab. Arthritis Rheum 2005;52:1224-6.
7. Schatteman L, Gyselbrecht L, De Clercq L, Mielants H. Treatment of refractory inflammatory monoarthritis in ankylosing spondylitis by intraarticular injection of infliximab. J Rheumatol 2006;33:82-5.
8. Sakellariou GT, Kakavouli G, Chatzigiannis I. Intraarticular injection of infliximab. J Rheumatol 2006;33:1912-3
9. Tak PP, Taylor PC, Breedveld FC, Smeets TJ, Daha MR, Klum PM, et al. Decrease in cellularity and expression of adhesion molecules by anti-tumor necrosis factor alpha monoclonal antibody treatment in patients with rheumatoid arthritis. Arthritis Rheum 1996;39:1077-81.
10. Taylor PC, Peters AM, Paleolog E, Chapman PT, Elliott MJ, McCloskey R, et al. Reduction of chemokine levels and leukocyte traffic to joints by tumor necrosis factor alpha blockade in patients with rheumatoid arthritis. Arthritis Rheum 2000;43:38-47.
11. Baeten D, Kruithof E, Van den Bosch F, Demetter P, Van Damme N, Cuvelier C, et al. Immunomodulatory effects of anti-tumor necrosis factor alpha therapy on synovium in spondyloarthropathy: histologic findings in eight patients from an open-label pilot study. Arthritis Rheum 2001;44:186-95.
12. Walker JG, Ahern MJ, Coleman M, Weedon H, Papangelis V, Beroukas D, et al. Expression of Jak3, STAT1, STAT4 and STAT6 in inflammatory arthritis: unique Jak3 and STAT4 expression in dendritic cells in seropositive rheumatoid arthritis. Ann Rheum Dis 2006;65:149-56.
13. Tak PP, van der Lubbe PA, Cauli A, Daha MR, Smeets TJ, Kluin PM, et al. Reduction of synovial inflammation after anti-CD4 monoclonal antibody treatment in early rheumatoid arthritis. Arthritis Rheum 1995;38:1457-65.